[1
]
From the Division of Nephrology and Clinical Immunology (T.R., F.E., J.F.) and Department
of Medical Statistics (C.F., R.-D.H.), RWTH Aachen University, Aachen, Bayer Pharma,
Kidney Diseases Research, Wuppertal (F.E.), Department of Nephrology, University of
Heidelberg, Heidelberg (C.S., M.Z.), Internal Medicine D, Department of Nephrology,
Hypertension and Rheumatology, University Hospital Muenster, Muenster (B.O.), University
Medical Center Hamburg-Eppendorf, Hamburg (U.P.), Department of Nephrology and Dieter
Scheffner Center for Medical Education, Charité Campus Mitte, Charité-Universitätsmedizin
Berlin, Berlin (H.P.), Department of Medicine V, University Medical Center Mannheim,
University of Heidelberg, Mannheim (U.B.), Department of Nephrology and Hypertension,
Diabetes and Endocrinology, Otto-von-Guericke University, Magdeburg (P.R.M.), Medical
Clinic III, Central Hospital Bremen, Bremen (U.K.), Department of Nephrology, University
Hospital Essen, University of Duisburg-Essen, Essen (O.W.), Clinic for Nephrology
and Rheumatology, University Medical Center Goettingen, Goettingen (O.G.), and Nephrologisches
Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität
(V.V.), and Department of Nephrology, Hypertension and Rheumatology, Munich General
Hospital (J.F.E.M.), Munich - all in Germany.